{"id":3316,"date":"2024-04-26T17:09:01","date_gmt":"2024-04-26T14:09:01","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=3316"},"modified":"2024-04-26T17:37:20","modified_gmt":"2024-04-26T14:37:20","slug":"novo-nordisk-turkiye-bir-kez-daha-en-iyi-isveren-secildi","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=3316","title":{"rendered":"Novo Nordisk T\u00fcrkiye, Bir Kez Daha \u2018En \u0130yi \u0130\u015fveren\u2019 Se\u00e7ildi"},"content":{"rendered":"\n

Danimarka merkezli global sa\u011fl\u0131k \u015firketi Novo Nordisk, Great Place to Work\u00ae Enstit\u00fcs\u00fc taraf\u0131ndan T\u00fcrkiye\u2019de bir kez daha \u2018En \u0130yi \u0130\u015fveren\u2019 se\u00e7ilerek, genel s\u0131ralamada 4. s\u0131raya y\u00fckseldi.<\/strong><\/p>\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

D\u00fcnyan\u0131n en b\u00fcy\u00fck vakf\u0131 Novo Nordisk Vakf\u0131 taraf\u0131ndan y\u00f6netilen ve 80 \u00fclkede 64 bin \u00e7al\u0131\u015fan\u0131yla faaliyet g\u00f6steren Novo Nordisk, T\u00fcrkiye\u2019de gelece\u011fe y\u00f6n veren tedavileriyle, diyabet, obezite ve nadir hastal\u0131klar ile ya\u015fayan bireylerin hayatlar\u0131n\u0131 iyile\u015ftirmek i\u00e7in \u00e7al\u0131\u015fmalar\u0131n\u0131 s\u00fcrd\u00fcr\u00fcyor. Novo Nordisk T\u00fcrkiye, En \u0130yi \u0130\u015fverenler listesinde \u00f6nceki y\u0131llara g\u00f6re \u00fcst s\u0131ralara y\u00fckselerek genel s\u0131ralamada 4. s\u0131rada yer ald\u0131.  <\/p>\n\n\n\n

100 y\u0131ll\u0131k bir ge\u00e7mi\u015fe ve k\u00f6kl\u00fc bir k\u00fclt\u00fcre sahip Novo Nordisk\u2019de \u00e7al\u0131\u015fanlar\u0131n \u015firketin de\u011ferleri olarak benimsedi\u011fi \u2018\u2019Novo Nordisk Tarz\u0131\u2019\u2019 do\u011frultusunda, a\u00e7\u0131k ileti\u015fim ve geri bildirim k\u00fclt\u00fcr\u00fcn\u00fcn \u00f6nceliklendirildi\u011fini belirten Novo Nordisk T\u00fcrkiye \u0130nsan Kaynaklar\u0131 K\u0131demli Direkt\u00f6r\u00fc Selim Necdet Ortega K\u0131z\u0131ler<\/strong>, bu prensiplerin bir sonucu olarak potansiyllerini s\u00fcrekli geli\u015fim ile ger\u00e7ekle\u015ftirdikleri, kapsay\u0131c\u0131l\u0131k ve \u00e7e\u015fitlili\u011fi destekleyen i\u015fveren yakla\u015f\u0131m\u0131yla sekt\u00f6rde fark yaratt\u0131klar\u0131n\u0131n alt\u0131n\u0131 \u00e7iziyor. \u0130\u015f-ya\u015fam dengesini \u00f6n plana \u00e7\u0131karan, \u00e7al\u0131\u015fanlar\u0131n hem mental hem de fiziksel sa\u011fl\u0131klar\u0131n\u0131 destekleyen \u0130K uygulamalar\u0131 ile \u00e7al\u0131\u015fanlar\u0131n geli\u015fimini destekleyen ve liderlik yolunda inisiyatif veren bir i\u015fveren olduklar\u0131n\u0131 s\u00f6zlerine ekleyen K\u0131z\u0131ler, \u201cNovo Nordisk insan hayat\u0131n\u0131 iyile\u015ftirmek i\u00e7in adanm\u0131\u015f \u00e7al\u0131\u015fanlar\u0131 ile g\u00fc\u00e7l\u00fc. Biz de \u00e7al\u0131\u015fanlar\u0131m\u0131za T\u00fcrkiye\u2019de ve yurtd\u0131\u015f\u0131nda hayat de\u011fi\u015ftiren kariyerlere sahip olmalar\u0131 i\u00e7in potansiyellerini ger\u00e7ekle\u015ftirmelerini destekliyoruz. \u00c7al\u0131\u015fma k\u00fclt\u00fcr\u00fcm\u00fczde, \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131n s\u00fcrekli daha iyisini yapmak i\u00e7in \u2018cesur\u2019 ve \u2018merakl\u0131\u2019 olmas\u0131n\u0131, hedeflerimize ula\u015fmak i\u00e7in denemekten vazge\u00e7memeyi, pozisyonlardan ba\u011f\u0131ms\u0131z \u2018beraber \u00e7al\u0131\u015fmay\u0131\u2019 ve i\u015f yap\u0131\u015f\u0131n merkezine inovasyonu almay\u0131 \u00f6nceliklendiyoruz\u201d dedi. K\u0131z\u0131ler, t\u00fcm bunlar\u0131n bir sonucu olarak \u0130nsan Kaynaklar\u0131 alan\u0131nda sayg\u0131n bir kurum olan Great Place to Work\u00ae Enstit\u00fcs\u00fc taraf\u0131ndan bir kez daha \u2018En \u0130yi \u0130\u015fveren\u2019 se\u00e7ilmenin mutlulu\u011funu ya\u015fad\u0131klar\u0131n\u0131 dile getirdi.<\/p>\n","protected":false},"excerpt":{"rendered":"

Danimarka merkezli global sa\u011fl\u0131k \u015firketi Novo Nordisk, Great Place to Work\u00ae Enstit\u00fcs\u00fc taraf\u0131ndan T\u00fcrkiye\u2019de bir kez daha \u2018En \u0130yi \u0130\u015fveren\u2019 se\u00e7ilerek, genel s\u0131ralamada 4. s\u0131raya y\u00fckseldi.<\/p>\n","protected":false},"author":1,"featured_media":3321,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,3],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3316"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3316"}],"version-history":[{"count":3,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3316\/revisions"}],"predecessor-version":[{"id":3340,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3316\/revisions\/3340"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/3321"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3316"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}